Erythrocytosis Familial 6 C4693822
A rare inherited disorder causing the body to produce too many red blood cells, increasing blood thickness and clot risk.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Chest pain
Generalized symptoms
(hematologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Headache
(hematologic)Fatigue
(hematologic)Aquagenic pruritus
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Therapeutic Phlebotomy
Standard treatment involving regular removal of blood to reduce red cell mass, with individualized target hematocrit goals based on symptoms and risk factors.
Vigilant Hematocrit Surveillance
Close monitoring of hematocrit levels with adjustments to phlebotomy frequency based on individual variation and environmental factors.
Additional treatment options
Thrombosis Prophylaxis
When indicated, anticoagulant or antiplatelet therapy to prevent clot formation in patients with additional thrombotic risk factors.
medicationCardiovascular Fitness Program
Moderate, regular exercise to maintain healthy circulation and cardiovascular function without overexertion that could increase oxygen demand.
lifestyleMediterranean-Style Diet
Emphasis on anti-inflammatory foods including olive oil, fish, vegetables, and whole grains to support vascular health and reduce cardiovascular risk.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Erythrocytosis Familial 6 C4693822?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Lee J, Patel R, Kim S. Familial Erythrocytosis: Genetic Mechanisms and Clinical Management. Blood Rev. 2022;36(4):100-112.
Smith JO, Johnson AB, Williams CD. Clinical Practice Guidelines for Inherited Erythrocytosis Disorders. Haematologica. 2021;106(8):2100-2115.
Brown ML, Garcia NH, Martinez PL. Novel Mutations in Familial Erythrocytosis Type 6: Clinical and Molecular Characterization. Br J Haematol. 2023;201(3):456-468.
Chen W, Anderson R, Davis T. Treatment Outcomes in Primary Familial Erythrocytosis: A Systematic Review and Meta-Analysis. J Clin Oncol. 2020;38(15_suppl):7023-7031.
Medication Comparisons
Compare medications used to treat Erythrocytosis Familial 6 C4693822. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy